Jubilant Profits Spurred By Foreign Business

Buoyed chiefly by earnings from its foreign businesses, India's pharmaceuticals and chemicals major Jubilant Organosys reported a net profit of 4 billion rupees ($98 million) for the year ending March 31

More from Archive

More from Scrip